The pharmaceutical company Eurofarma has just closed the acquisition of Chilean Medipharm, SB companies. The purchase, which positions the Brazilian for the 21st position in the Chilean market, is inserted in its strategic plan, which has as its goal that its international operations respond, in 2022, by 30% of the total revenues of the company. The value of the business has not been disclosed.
O Estado de S.Paulo - 19/06/2019
News Item translated automatically
Click HERE to see original
